Glycosylation in infectious diseases
My lab studies neutralising antibody responses in viral infection to apply to vaccine development. We are particularly interested in broadly neutralising antibodies that target the N-linked glycans on the HIV envelope glycoprotein, Env, and the principles that control HIV Env glycosylation.
Keywords
Vaccine / virus / glycobiology / neutralizing antibody / HIV / protein glycosylation